YOLFTbeta
cbdMD Inc

cbdMD Inc

YCBD · AMEX · Healthcare / Drug Manufacturers - Specialty & Generic

0.374USD-0.02 (-4.69%)

Price History

Full chart

Market Stats

Previous Close0.3924
Open0.385
Day Range0.3627 – 0.3997
52-Week Range0.41 – 2.56
Volume299.16K
Market Cap5.26M
P/E (TTM)2.04
Forward P/E714.29
EPS0.23
Dividend Yield0.00%
Beta2.17
50-Day Avg0.5078
200-Day Avg0.7735

About

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. T. Ronan Kennedy
  • Employees42
  • Headquarters2101 Westinghouse Blvd, Charlotte, NC, United States, 28273, USA
  • Websitehttps://www.cbdmd.com

Leadership

  • Mr. T. Ronan KennedyCEO, CFO, Principal Executive Officer & Director · b. 1980
  • Mr. Bradley WhitfordChief Accounting Officer, Treasurer & Secretary · b. 1982
  • Dr. Sibyl Swift Ph.D.CSO, VP of Regulatory Affairs & Director · b. 1981
  • Mr. Zeb BookerChief Technology Officer
  • Mr. Lance BlundellGeneral Counsel · b. 1971
  • Mr. Francisco MangualSenior VP of Sales · b. 1979
  • Mr. Wade BrownChief Marketing Officer
  • Mr. David JohnsonSenior VP of Business Development · b. 1970

Financials

Income Statement

Currency: USD2015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue12.54K2.03M4.47M459.09K23.65M41.88M44.48M35.40M24.16M19.48M19.19M
Growth (%)-+16100.65%+120.27%-89.74%+5051.82%+77.09%+6.20%-20.41%-31.77%-19.35%-1.50%
Cost of Revenue7.62K1.62M1.36M326.56K9.14M15.51M15.51M14.90M11.12M8.64M7.22M
Gross Profit4.92K413.13K3.12M132.53K14.51M26.37M28.97M20.50M13.04M10.85M11.97M
Gross Margin39.23%20.34%69.71%28.87%61.37%62.96%65.13%57.91%53.97%55.67%62.37%
Operating Expense1.30M4.15M3.36M1.93M28.88M43.95M48.58M37.81M22.31M14.04M14.13M
Operating Income-1.30M-3.73M-239.29K-1.80M-14.36M-17.58M-19.62M-17.31M-9.27M-3.19M-2.16M
Operating Margin-10360.37%-183.76%-5.35%-391.44%-60.72%-41.98%-44.10%-48.90%-38.37%-16.37%-11.27%
EBITDA--3.69M-168.01K-1.57M-14.07M-15.68M-22.01M-67.11M-20.01M-1.85M-244.98K
EBITDA Margin--181.55%-3.75%-342.97%-59.49%-37.44%-49.48%-189.57%-82.84%-9.50%-1.28%
Net Income-1.13M-3.36M-1.74M-412.07K-50.43M12.60M-23.39M-70.08M-22.94M-3.70M-2.04M
Net Income Margin-9017.94%-165.22%-38.85%-89.76%-213.21%30.09%-52.60%-197.96%-94.96%-18.99%-10.63%
R&D-----424.45K1.42M633.39K173.04K39.02K33.86K
R&D as % of Total Revenue-----1.01%3.20%1.79%0.72%0.20%0.18%
Interest Expense0154.98K500.63K95571.93M57.69M28.93K16.25K-29.51K-
Interest Expense % of Total Revenue0.00%7.63%11.19%0.21%304.13%137.73%0.07%0.05%-0.15%-

Balance Sheet

Currency: USD2015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets1.82M1.62M7.07M15.02M94.52M110.84M124.88M40.79M16.20M10.58M10.42M
Total Liabilities545.41K1.92M1.92M998.46K56.91M31.66M21.74M9.37M7.16M8.62M3.19M
Total Equity1.39M363.43K4.21M12.61M37.60M79.18M103.14M31.42M9.03M1.96M7.23M
Cash546.46K34.26K284.25K4.28M4.69M14.82M26.41M6.72M1.80M2.45M2.26M
Total Debt331.23K797.55K360.00K-194.47K8.68M6.07M4.87M3.68M1.27M778.24M
Net Debt-215.23K763.29K75.75K-4.28M-4.50M-6.14M-20.34M-1.85M1.89M-1.18M775.98M

Cash Flow

Currency: USD2015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow-1.71M-2.90M-2.33M-5.57M-15.38M-10.66M-14.09M-14.97M-4.30M-352.79K-1.45M
Investing Cash Flow-255.24K-127.26K152.31K-683.56K-2.13M-1.57M-2.55M-688.68K702.45K-290.01K-184.17K
Financing Cash Flow2.51M2.51M2.43M10.25M17.92M22.37M28.23M-4.04M-1.32M1.30M1.45M
Capital Expenditure255.24K127.26K7.97K383.56K1.25M1.32M2.34M688.68K297.55K290.01K184.18K
Free Cash Flow--3.02M-2.34M-5.96M-16.63M-11.98M-16.44M-15.66M-4.60M-642.81K-1.64M
Dividends Paid--29.18K366.85K366.85K366.85K2.55M4.00M3.67M0-
FCF to OCF-104.39%100.34%106.88%108.12%112.38%116.62%104.60%106.92%182.21%112.68%
Dividend Paid to FCF---1.25%-6.16%-2.21%-3.06%-15.54%-25.56%-79.76%0.00%-

Earnings

Report DateMay 4, 2017Oct 27, 2017Feb 15, 2018May 15, 2018Aug 14, 2018Dec 12, 2018Feb 14, 2019May 15, 2019Aug 14, 2019Dec 18, 2019Feb 13, 2020May 18, 2020Aug 12, 2020Dec 22, 2020Feb 9, 2021May 12, 2021Aug 12, 2021Dec 17, 2021Feb 10, 2022May 13, 2022Aug 11, 2022Dec 15, 2022Feb 13, 2023May 15, 2023Aug 10, 2023Dec 22, 2023Feb 13, 2024May 15, 2024Aug 14, 2024Dec 20, 2024Feb 13, 2025May 15, 2025Aug 14, 2025Dec 19, 2025Feb 17, 2026May 14, 2026Aug 13, 2026
EPS Estimate0.000.00------18.00-36.00-0.17-46.62-25.20-9.00-0.01-3.60-14.40-21.60-0.04-14.40-14.40-18.00-0.03-126.00-0.04-28.80-0.76-5.92-6.00-4.96-0.45-2.96-1.60-0.16-0.07-0.06-0.05-0.03
EPS Actual-0.13-0.03-0.170.170.03-0.10-0.06-31.10-428.400.79-51.05-55.87-10.04-0.14-10.62-28.30-42.12-0.07-126.00-36.00-198.00-0.26-28.80-0.03-9.28-1.21-5.21-10.80-1.20-0.29-1.76-1.90-0.21-0.08-0.04-0.08-0.11
Surprise--------72.78%-1090.00%564.71%-9.50%-121.71%-11.56%-1300.00%-195.00%-96.53%-95.00%-75.00%-775.00%-150.00%-1000.00%-759.00%77.14%25.00%67.78%-59.21%11.99%-80.00%75.81%34.82%40.54%-18.75%-31.25%-14.29%33.33%-60.00%-266.67%
Timing-----After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap5.26M
Enterprise Value5.22M
Trailing P/E2.04
Forward P/E714.29
Price / Sales0.25
Price / Book0.62
EPS0.23
Book Value0.773
Revenue (TTM)20.93M
Gross Profit (TTM)12.07M
EBITDA-1.89M
Profit Margin-13.80%
Operating Margin-20.36%
Return on Equity-40.33%
Return on Assets-15.75%
Shares Outstanding11.21M
Shares Float10.91M
Beta2.17
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 2.00
  • Buy
    1

Stock Splits

  • May 7, 20251:8
  • Apr 25, 20231:45